Visioneering Technologies, Inc. (VTI:ASX)
$1.18
0.035 (3.06%)
MCAP $27.88M
Last trade 15.36pm 27/07/2021
20mins delayed
Latest Announcements
15.13pm 27/07/2021VTIVisioneering Technologies, Inc.
11.37am 27/07/2021VTIVisioneering Technologies, Inc.
345
MCap
26/07/2021VTIVisioneering Technologies, Inc.
21/07/2021VTIVisioneering Technologies, Inc.
16/07/2021 Price SensitivePSVTIVisioneering Technologies, Inc.
13/07/2021VTIVisioneering Technologies, Inc.
02/07/2021VTIVisioneering Technologies, Inc.
02/07/2021VTIVisioneering Technologies, Inc.
985
MCap
Company Overview
Visioneering Technologies, Inc is an eye care company. The Company is engaged in designing, manufacturing, selling and distributing contact lenses. It offers NaturalVue Multifocal contact lens for the treatment of myopia. Its product, the NaturalVue Multifocal (etafilcon A) 1 Day Contact Lens (NaturalVue MF), is used by patient populations with vision needs. It provides its product for children who have blurry distance vision through their childhood and adolescence, a condition called myopia progression. It also offers its products for persons over the age of 40 who have myopia and are losing their ability to see near objects, a condition called presbyopia. It also sells NaturalVue Sphere, which is a contact lens for the correction of blurry distance vision. It is also developing products for those with astigmatism. Its products are used by Eye Care Professionals (ECPs) to treat myopia in children and middle-age and older adults with correction of near and distance vision.
